Aliénor Berges
Impact in
-
- PARP inhibition in cancer therapy
-
- Amyloidosis: Diagnosis, Treatment, Outcomes
- DNA Repair Mechanisms
Papers in
-
- Statistical Methods in Clinical Trials 9
- Oncology 6
- PARP inhibition in cancer therapy 5
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Duncan Richards (3 shared papers)Louise M. Cookson (3 shared papers)Julian David Gillmore (2 shared papers)Marianna Fontana (2 shared papers)Mark B. Pepys (2 shared papers)Massimo Pinzani (1 shared paper)James Moon (2 shared papers)Philip Nigel Hawkins (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Current Alzheimer Research (2 papers)PLoS ONE (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Aliénor Berges
28 papers receiving 948 citations
Peers
Comparison fields: 5 of 90
- Oncology 170
- Molecular Biology 395
- Immunology 99
- Cellular and Molecular Neuroscience 70
- Radiology, Nuclear Medicine and Imaging 80
Countries citing papers authored by Aliénor Berges
This map shows the geographic impact of Aliénor Berges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliénor Berges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliénor Berges more than expected).
Fields of papers citing papers by Aliénor Berges
This network shows the impact of papers produced by Aliénor Berges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliénor Berges. The network helps show where Aliénor Berges may publish in the future.
Co-authors
The 25 scholars most cited alongside Aliénor Berges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 301 | |
| 2 | 2014 | 97 | |
| 3 | 2021 | 95 | |
| 4 | 2014 | 84 | |
| 5 | 2021 | 70 | |
| 6 | 2013 | 59 | |
| 7 | 2016 | 44 | |
| 8 | 2013 | 33 | |
| 9 | 2015 | 29 | |
| 10 | 2018 | 26 | |
| 11 | 2019 | 25 | |
| 12 | 2018 | 19 | |
| 13 | 2019 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2015 | 11 | |
| 16 | 2013 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2010 | 6 | |
| 20 | 2013 | 6 |
About Aliénor Berges
Aliénor Berges is a scholar working on Statistics and Probability, Oncology, Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 985 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (9 papers), PARP inhibition in cancer therapy (5 papers), Pharmaceutical studies and practices (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Migraine and Headache Studies (2 papers), Alzheimer's disease research and treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (170 citations), Molecular Biology (395 citations), Immunology (99 citations), Cellular and Molecular Neuroscience (70 citations) and Radiology, Nuclear Medicine and Imaging (80 citations). Aliénor Berges has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Duncan Richards, Louise M. Cookson, Julian David Gillmore, Marianna Fontana, Mark B. Pepys, Massimo Pinzani, James Moon, Philip Nigel Hawkins, James M. Ritter and Thirusha Lane. Their work appears in journals such as Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Current Alzheimer Research, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.